Expiration date: 01/2025
Chondartron is an injection solution for dogs and cats with diseases of the musculoskeletal system. In appearance, the drug is a colorless transparent liquid.
Structure
As active substances, Chondartron for injection contains matrix tinctures of vegetable, organic origin and mineral components (in 1000 ml): Rhododendron Ø=D1 20 ml; Rhus toxicodendron 4 ml; Ledum palustre Ø= D1 0.2 ml; Symphytum 9 ml; Apis mellifica Ø=D1 1 nl; Causticum Hahnemanni D4 1 mg; Calcium fluoratum D4 1 mcg; Lithium carbonicum D4 1 mcg; Sulphur Ø=D4 0.1 ml; Comarum palustre 40 nl and excipients: methyl parahydroxybenzoate - 0.5 g, sodium chloride - 5.8 g, sodium acetate tri hydrate - 2.0 g, hydrochloric acid to pH 5.4, ethyl alcohol 95% - 5.26 g, water for injection up to 1000 ml.
PHARMACOLOGICAL PROPERTIES
Chondartron refers to combined homeopathic medicines. It has anti-inflammatory, analgesic, chondroprotective and regenerating effects in diseases of the musculoskeletal system in dogs and cats.
According to the degree of exposure to the body, the drug belongs to low-hazard substances (hazard class 4 according to GOST 12.1.00776), does not have a locally irritating and sensitizing effect.
INDICATIONS
Chondartron is prescribed to dogs and cats for the prevention and treatment of: acute diseases of the joints and periarticular structures (arthritis, bursitis, synovitis, etc.); diseases and injuries of the tendon-ligamentous apparatus (tendinitis, tendovagnitis, sprains, partial tendon ruptures, etc.); osteoarthritis, including those resulting from various osteochondropathies; arthrosis; recovery after surgery on joints and tendon-ligamentous apparatus.
DOSAGE AND APPLICATION
Chondartron injections are used intramuscularly or subcutaneously 2-3 times a day for 10-14 days: dogs and cats: 0.1 ml per 1 kg of animal weight (min. 0.5 ml, max. 4.0 ml); horses 8.0-10.0 ml; cattle 5.0 ml; calves 2.5-3.0 ml; sheep, goats 3.0 ml.
SPECIAL INSTRUCTIONS
Symptoms of overdose in animals have not been established.
The peculiarities of the drug's action during its first use and cancellation have not been established.
Omissions should be avoided when administering the next dose of the drug, as this can lead to a decrease in therapeutic and preventive effectiveness. If one dose is missed, the use of the drug should be resumed as soon as possible in the same dose and according to the same scheme.
The use of Chondartron does not exclude the use of other drugs for etiotropic, pathogenetic and symptomatic therapy.
Chondartron is not intended for use by productive animals.
Contraindications
Contraindication to the use of the drug is an individual hypersensitivity of the animal to its components.
SIDE EFFECTS
When using Chondartron in accordance with this instruction, side effects and complications are usually not noted. With increased individual sensitivity and the manifestation of allergic reactions, the use of the drug is discontinued and antihistamines and symptomatic therapy are prescribed to the animal.
SHELF LIFE AND STORAGE
The hondartron is stored in the manufacturer's closed packaging, separately from food and feed, in a dry place protected from direct sunlight, at a temperature from 0 ° C to 25 ° C.
The shelf life of the drug, subject to storage conditions in the manufacturer's closed packaging in a closed package, is 3 years from the date of production, after the first opening of the bottle - 30 days. It is forbidden to use after the expiration date.
It should be kept out of the reach of children. Unused medicinal product is disposed of in accordance with the requirements of the legislation.
